Magnetic resonance spectroscopy in the diagnosis of alzheimer's disease

Authors

DOI:

https://doi.org/10.33448/rsd-v9i11.10349

Keywords:

Spectroscopy in AD; Diagnosis of AD; ERM at AD.

Abstract

Introduction: Alzheimer's disease (AD) is a progressive and irreversible neurodegenerative pathology that causes memory loss and several cognitive disorders, such as memory impairment, language difficulties and behavioral changes. This pathology appears with a higher prevalence in individuals with more advanced age (+65 years). Due to the characteristics of AD and its various complementary methods for diagnosis, the objective of this work was to evaluate the Proton Spectroscopy by Magnetic Resonance for diagnosis of this pathology. Methodology: This work refers to a qualitative exploratory literature search. In which searches were carried out on national and international databases, Medline, Scientific Electronic Electronic Library Online (SCIELO), Scholar Google (Google Scholar), Pubmed and Virtual Health Library (Bvs), considering studies in Portuguese languages ​​to be eligible. and English. Results: AD affects mainly people over 60 years of age, increasing the probability with the aging of individuals, since its manifestations occur due to cognitive and memory degradation, thus constituting a neurodegenerative pathology. The diagnosis of AD is pre-established with the exclusion of other possible causes for dementia. This exclusion is performed through clinical, laboratory and brain neuroimaging exams. Conclusion: The neuroimaging technique by proton spectroscopy in magnetic resonance demonstrates specificity in the quantification of the metabolites of N-acetylaspartate (NAA), Myo-inositol (MI), choline (Cho), Cho and Creatine (Cr) in AD, being a viable alternative for the in vivo study of the patient, since it does not represent an invasive analysis.

References

Alzheimer´s Disease International. World Alzheimer Report 2019.

Aprahamian, I., Martinelli, J. E., & Yassuda, M. S. (2009). Doença de Alzheimer: revisão da epidemiologia e diagnóstico. Rev Bras Clin Med, 7(6), 27-35.

Gil, A., Blasco, C., & Celda, B. (2007). Demencias: contribución diagnóstica de la imagen y de la espectroscopia de resonancia magnética de protón. Neurología, 22(5), 267-274.

Barros, A. C., Lucatelli, J. F., Maluf, S. W., & Andrade, F. M. D. (2009). Influência genética sobre a doença de Alzheimer de início tardio. Archives of Clinical Psychiatry (São Paulo), 36(1), 16-24.

Barros, E. P.S. A Utilização de Ressonância Magnética no auxílio do Diagnóstico da Doença de Alzheimer. (Especialização) Imagenologia Biomédica CCE. Recife-PE. 2017.

Caramelli, P., Teixeira, A. L., Buchpiguel, C. A., Lee, H. W., Livramento, J. A., Fernandez, L. L., & Anghinah, R. (2011). Diagnóstico de doença de Alzheimer no Brasil: exames complementares. Dementia & Neuropsychologia, 5(3), 167-177.

Cavalcante, S. G. Aspectos genéticos da doença de alzheimer, 14º Congresso Nacional De Iniciação Científica – CONIC, 2014.

Engelhardt, E., Moreira, D. M., Laks, J., & Cavalcanti, J. L. S. (2005). Alzheimer's disease and proton magnetic resonance spectroscopy of limbic regions: a suggestion of a clinical-spectroscopic staging. Arquivos de neuro-psiquiatria, 63(2A), 195-200.

Fonseca, F. I. R. M. D., Dedivitis, R. A., Smokou, A., Lascane, E., Cavalheiro, R. A., Ribeiro, E. F., ... & Santos, E. B. D. (2010). Frequência de automedicação entre acadêmicos de faculdade de medicina. Diagn. tratamento.

Gambarota, G. (2017). Optimization of metabolite detection by quantum mechanics simulations in magnetic resonance spectroscopy. Analytical biochemistry, 529, 65-78.

Oliveira, M. D. F., Ribeiro, M., Borges, R., & Luginger, S. (2005). Doença de Alzheimer–perfil neuropsicológico e tratamento. Site científico:[www. psicologia. com. pt].

Picon, P. D., Gadelha, M. I. P., & Beltrame, A. (2013). Protocolos clínicos e diretrizes terapêuticas.

Rapalino, O., & Ratai, E. M. (2016). Multiparametric imaging analysis: magnetic resonance spectroscopy. Magnetic Resonance Imaging Clinics, 24(4), 671-686.

Santos, J. B. D. (2017). Utilização da neuroimagem no diagnóstico complementar na Doença de Alzheimer.

Sereniki, A., & Vital, M. A. B. F. (2008). Alzheimer's disease: pathophysiological and pharmacological features. Revista de Psiquiatria do Rio Grande do Sul, 30(1), 0-0.

Silva, M. B., Arruda, G., & Follador, F. A. C. (2014). FATORES GENÉTICOS ENVOLVIDOS NA DOENÇA DE ALZHEIMER: UMA REVISÃO TEÓRICA. In III Congresso Nacional de Pesquisa em Ciências Sociais Aplicadas–III CONAPE, Francisco Beltrão/PR.

Souza, A. S. D. (2005). Espectroscopia de prótons na demência de Alzheimer e no comprometimento cognitivo (Doctoral dissertation, Universidade de São Paulo).

Downloads

Published

02/12/2020

How to Cite

SOUZA, K. S. .; MIRANDA, F. S. L. .; SILVA, M. R. F. da .; LEITE, K. M. .; SILVA, J. dos S. .; SILVA, R. P. L. da .; OLIVEIRA, M. B. M. de .; BRITO, L. P. de .; SILVA, R. R. dos S. .; SANTOS, M. D. V. .; LIMA, F. L. O. .; SANTOS , G. dos .; SILVA, D. C. B. da .; BARROS, E. P. da S. Magnetic resonance spectroscopy in the diagnosis of alzheimer’s disease. Research, Society and Development, [S. l.], v. 9, n. 11, p. e71991110349, 2020. DOI: 10.33448/rsd-v9i11.10349. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/10349. Acesso em: 22 nov. 2024.

Issue

Vol. 9 No. 11

Section

Review Article

License

Copyright (c) 2020 Karolayne Silva Souza; Flávia Steffany Leite Miranda; Milena Roberta Freire da Silva; Kaleen Massari Leite; Jaqueline dos Santos Silva; Renata Pereira Lima da Silva; Maria Betânia Melo de Oliveira; Leandro Paes de Brito; Rodrigo Reges dos Santos Silva; Milena Danda Vasconcelos Santos; Felicson Leonardo Oliveira Lima; Graziele dos Santos ; Diego Canuto Bispo da Silva; Everton Philipe da Silva Barros

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.